Ritholtz Wealth Management’s Quest Diagnostics DGX Stock Holding History

Ritholtz Wealth Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,862	Closed	-$402K	–	713
2023 Q2	$402K	Sell	2,862 -298	-9%	-$41.1K	0.02%	477
2023 Q1	$447K	Sell	3,160 -1,666	-35%	-$238K	0.02%	435
2022 Q4	$755K	Buy	4,826 +289	+6%	+$41.5K	0.04%	290
2022 Q3	$557K	Sell	4,537 -1,132	-20%	-$149K	0.03%	372
2022 Q2	$754K	Buy	5,669 +926	+20%	+$126K	0.05%	236
2022 Q1	$649K	Buy	4,743 +1,195	+34%	+$167K	0.04%	255
2021 Q4	$614K	Buy	3,548 +1,743	+97%	+$265K	0.04%	255
2021 Q3	$262K	Buy	+1,805	New	+$264K	0.02%	402

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ritholtz Wealth Management's DGX Position: Q3 2023 in Review

Ritholtz Wealth Management sold out of Quest Diagnostics (DGX) in Q3 2023, closing a stake of 2,862 shares — an estimated $402K sold.

Ritholtz Wealth Management first reported a position in DGX in Q3 2021 and held it in 8 quarters. The position peaked at $755K in Q4 2022. 794 funds tracked by Wall St. Rank hold DGX as of Q3 2023.

Ritholtz Wealth Management reported no remaining Quest Diagnostics position as of Q3 2023 after selling out during the quarter.
Ritholtz Wealth Management sold 2,862 Quest Diagnostics shares in Q3 2023, an estimated $402K.
Ritholtz Wealth Management first reported a position in Quest Diagnostics in Q3 2021 and held it in 8 quarters.
Ritholtz Wealth Management's Quest Diagnostics position peaked at $755K in Q4 2022.
794 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2023.

Based on Ritholtz Wealth Management's 13F filing for Q3 2023, filed 13 Oct 2023.